Bevacizumab and stereotactic radiosurgery achieved complete response for pediatric recurrent medulloblastoma.
Zhao, Ming
Bevacizumab and stereotactic radiosurgery achieved complete response for pediatric recurrent medulloblastoma. [electronic resource] - Journal of cancer research and therapeutics Sep 2018 - S789-S792 p. digital
Publication Type: Case Reports; Letter
1998-4138
10.4103/jcrt.JCRT_990_15 doi
Bevacizumab--administration & dosage
Child, Preschool
Combined Modality Therapy
Humans
Male
Medulloblastoma--drug therapy
Neoplasm Recurrence, Local--drug therapy
Prognosis
Radiosurgery
Remission Induction
Salvage Therapy
Treatment Outcome
Bevacizumab and stereotactic radiosurgery achieved complete response for pediatric recurrent medulloblastoma. [electronic resource] - Journal of cancer research and therapeutics Sep 2018 - S789-S792 p. digital
Publication Type: Case Reports; Letter
1998-4138
10.4103/jcrt.JCRT_990_15 doi
Bevacizumab--administration & dosage
Child, Preschool
Combined Modality Therapy
Humans
Male
Medulloblastoma--drug therapy
Neoplasm Recurrence, Local--drug therapy
Prognosis
Radiosurgery
Remission Induction
Salvage Therapy
Treatment Outcome